These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8993483)

  • 1. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
    Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
    Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
    Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
    [No Abstract]   [Full Text] [Related]  

  • 3. New piece in Alzheimer's puzzle.
    Travis J
    Science; 1993 Aug; 261(5123):828-9. PubMed ID: 8346434
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein E and Alzheimer's disease.
    Scott J
    Lancet; 1993 Sep; 342(8873):696. PubMed ID: 8103818
    [No Abstract]   [Full Text] [Related]  

  • 5. ApoE, amyloid, and Alzheimer's disease.
    Hardy J
    Science; 1994 Jan; 263(5146):454-5. PubMed ID: 8290946
    [No Abstract]   [Full Text] [Related]  

  • 6. New gene tied to common form of Alzheimer's.
    Marx J
    Science; 1998 Jul; 281(5376):507, 509. PubMed ID: 9705719
    [No Abstract]   [Full Text] [Related]  

  • 7. APOE in Alzheimer's disease and neurodegeneration.
    Butterfield DA; Johnson LA
    Neurobiol Dis; 2020 Jun; 139():104847. PubMed ID: 32209402
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
    Hyman BT; Gomez-Isla T; West H; Briggs M; Chung H; Growdon JH; Rebeck GW
    Ann N Y Acad Sci; 1996 Jan; 777():158-65. PubMed ID: 8624079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: treatment research finds new targets.
    Hodes RJ
    J Am Geriatr Soc; 1994 Jun; 42(6):679-81. PubMed ID: 8201156
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
    Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
    J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR spectroscopy, APOE genotype, and evolving β-amyloid pathology: What is being detected and when.
    Kantarci K; Goldberg TE
    Neurology; 2016 May; 86(19):1750-1. PubMed ID: 27164709
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE4: is it the absence of good or the presence of bad?
    Ashford JW
    J Alzheimers Dis; 2002 Jun; 4(3):141-3. PubMed ID: 12226532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3.
    Rebeck GW; Kindy M; LaDu MJ
    J Alzheimers Dis; 2002 Jun; 4(3):145-54. PubMed ID: 12226533
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease.
    Schenk D; Lieberburg I; Motter R; Seubert P
    Ann N Y Acad Sci; 1996 Dec; 802():92-100. PubMed ID: 8993488
    [No Abstract]   [Full Text] [Related]  

  • 17. What's next for Alzheimer treatment?: while Aβ isn't out of the picture yet, several other therapeutic routes are being explored.
    Schwartz A
    Ann Neurol; 2013 Apr; 73(4):A7-9. PubMed ID: 24643982
    [No Abstract]   [Full Text] [Related]  

  • 18. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease.
    Selkoe DJ
    Cold Spring Harb Symp Quant Biol; 1996; 61():587-96. PubMed ID: 9246485
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration.
    Obulesu M; Somashekhar R; Venu R
    Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.